Clearly yes; all five(5) patents we own are still in place for the upcoming years in the US; covering the device itself, the machine technology to manufacture and pack them and the formulations (three different antibiotics) have been bought from the former owner by DS TECHNOLOGY.
A comprehensive list of IP coverage can only be provided once a CDA has been signed…Content of IP rights can also only be disclosed once a CDA has been signed…
Yes, a total of 9. Cefpodoxime granules for oral suspension 60, 80, 100 mg Clarithromycin granules for oral suspension 125 mg, 187.5 mg and 250 mg Amoxicillin/Clavulanic acid granules for oral suspension (7:1) 200 mg/28.5 mg; 300 mg/42.75 mg; 400 mg/57 mg
The regulations changed since the first marketing authorizations have been granted, these dossiers need to be partly reworked or amended. However, this effort is far less time consuming than doing a new dossier from scratch; In principle, DS TECHNOLOGY does not want to own new pharma dossiers, but act as a broker; if partner companies are willing to out-lisence their pharmaceutical dossiers, DST again would act as a broker for such as products in development are: